Interaction médicamenteuse: Arixtra Solution for injection
Générique: fondaparinux
Substance active: Groupe ATC: B01AX05 - fondaparinux
Teneur en substance active: 1,5MG/0,3ML, 10MG/0,8ML, 2,5MG/0,5ML, 5MG/0,4ML, 7,5MG/0,6ML
Emballage: Pre-filled syringe